Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from YSB Inc. ( (HK:9885) ).
YSB Inc. reported significant growth in its interim results for the first half of 2025, with an 11.7% increase in revenue and a 258% rise in profit attributable to owners. Despite challenges in the pharmaceutical industry due to economic downturns and policy adjustments, YSB Inc. capitalized on opportunities presented by China’s healthcare policies. The company enhanced its digital solutions and expanded its user base, achieving breakthroughs in scale expansion and profit optimization through technology-driven strategies and ecosystem collaboration.
More about YSB Inc.
YSB Inc. operates in the pharmaceutical and healthcare industry, focusing on primary care development and improving medicine accessibility. The company leverages an omni-channel layout strategy to provide digital solutions and collaborates with third-party sellers to enhance its online marketplace and self-operation business.
Average Trading Volume: 8,758,813
Technical Sentiment Signal: Buy
Learn more about 9885 stock on TipRanks’ Stock Analysis page.